| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Benefit-Risk Assessment of Agomelatine in the Treatment of Major Depression
|
Howland, Robert H.
|
|
2011
|
|
9 |
p. 709-731
|
article
|
| 2 |
A Comparison of Reported Gastrointestinal and Thromboembolic Events Between Rofecoxib and Celecoxib Using Observational Data
|
Kasliwal, Rachna
|
|
2005
|
|
9 |
p. 803-816
|
article
|
| 3 |
A Computerized Physician Order Entry Set Designed to Improve Safety of Intravenous Haloperidol Utilization
|
Muzyk, Andrew J.
|
|
2012
|
|
9 |
p. 725-731
|
article
|
| 4 |
A Computerized Physician Order Entry Set Designed to Improve Safety of Intravenous Haloperidol Utilization
|
Muzyk, Andrew J.
|
|
2012
|
|
9 |
p. 725-731
|
article
|
| 5 |
A Computerized Physician Order Entry Set Designed to Improve Safety of Intravenous Haloperidol Utilization
|
Muzyk, Andrew J.
|
|
|
|
9 |
p. 725-731
|
article
|
| 6 |
Active Surveillance versus Spontaneous Reporting for First-Line Antiretroviral Medicines in Namibia: A Cost–Utility Analysis
|
Mann, Marita
|
|
2016
|
|
9 |
p. 859-872
|
article
|
| 7 |
Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors
|
Angamo, Mulugeta Tarekegn
|
|
2016
|
|
9 |
p. 847-857
|
article
|
| 8 |
Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand
|
Walton, Muireann
|
|
|
|
9 |
p. 867-879
|
article
|
| 9 |
Adverse Gastrointestinal Events with Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Nested Case–Control Study
|
Campbell, Robert J.
|
|
2014
|
|
9 |
p. 723-733
|
article
|
| 10 |
Adverse Reactions to Contrast Media: An Analysis of Spontaneous Reports in the Database of the Pharmacovigilance Programme of India
|
Kalaiselvan, Vivekanandan
|
|
2014
|
|
9 |
p. 703-710
|
article
|
| 11 |
Advice on Drug Safety in Pregnancy
|
Widnes, Sofia K. Frost
|
|
2008
|
|
9 |
p. 799-806
|
article
|
| 12 |
A Model for Decision Support in Signal Triage
|
Levitan, Bennett
|
|
2008
|
|
9 |
p. 727-735
|
article
|
| 13 |
An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System
|
Iyer, Geetha
|
|
2017
|
|
9 |
p. 799-808
|
article
|
| 14 |
Antidepressants and the Risk of Hemorrhagic Stroke in the Elderly: a Nested Case–Control Study
|
Schäfer, Wiebke
|
|
2019
|
|
9 |
p. 1081-1089
|
article
|
| 15 |
Anti-tumor Necrosis Factor-Alpha Therapy and Hypoglycemia: A Real-World Pharmacovigilance Analysis
|
Zhou, Yu
|
|
|
|
9 |
p. 951-959
|
article
|
| 16 |
A Pathway to Improved Prospective Observational Post-Authorization Safety Studies
|
Kiri, Victor A.
|
|
2012
|
|
9 |
p. 711-724
|
article
|
| 17 |
A Pathway to Improved Prospective Observational Post-Authorization Safety Studies
|
Kiri, Victor A.
|
|
2012
|
|
9 |
p. 711-724
|
article
|
| 18 |
A Pathway to Improved Prospective Observational Post-Authorization Safety Studies
|
Kiri, Victor A.
|
|
|
|
9 |
p. 711-724
|
article
|
| 19 |
A Scoping Review of Non-Medical and Extra-Medical Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
|
Brennan, Rebekah
|
|
|
|
9 |
p. 917-928
|
article
|
| 20 |
Assessing Case Fatality on Cases of Thrombosis with Concurrent Thrombocytopenia Following COVID-19 Vaccine AstraZeneca (Vaxzevria) in the United Kingdom: A Review of Spontaneously Reported Data
|
Lane, Samantha
|
|
|
|
9 |
p. 1003-1008
|
article
|
| 21 |
Association Between Intravitreal Aflibercept and Serious Non-ocular Haemorrhage Compared with Intravitreal Ranibizumab: A Multicentre Observational Cohort Study
|
Sultana, Janet
|
|
|
|
9 |
p. 943-952
|
article
|
| 22 |
Association Between Statin Use and Bell’s Palsy: A Population-Based Study
|
Hung, Shih-Han
|
|
2014
|
|
9 |
p. 735-742
|
article
|
| 23 |
Augmenting Product Defect Surveillance Through Web Crawling and Machine Learning in Singapore
|
Ang, Pei San
|
|
|
|
9 |
p. 939-948
|
article
|
| 24 |
Authors’ Reply to Braillon and Martin’s Comment on “Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)”
|
Bahri, Priya
|
|
|
|
9 |
p. 1011-1013
|
article
|
| 25 |
Authors’ Reply to Cappello et al. Comment on: “Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System”
|
Fusaroli, Michele
|
|
|
|
9 |
p. 919-920
|
article
|
| 26 |
Auto-Generated Physiological Chain Data for an Ontological Framework for Pharmacology and Mechanism of Action to Determine Suspected Drugs in Cases of Dysuria
|
Hayakawa, Masayo
|
|
2019
|
|
9 |
p. 1055-1069
|
article
|
| 27 |
BAHAMA: A Bayesian Hierarchical Model for the Detection of MedDRA®-Coded Adverse Events in Randomized Controlled Trials
|
Revers, Alma
|
|
|
|
9 |
p. 961-970
|
article
|
| 28 |
Bayesian Modeling for the Detection of Adverse Events Underreporting in Clinical Trials
|
Barmaz, Yves
|
|
|
|
9 |
p. 949-955
|
article
|
| 29 |
Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster
|
Yamaoka, Kunihiro
|
|
|
|
9 |
p. 823-840
|
article
|
| 30 |
Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster
|
Yamaoka, Kunihiro
|
|
2016
|
|
9 |
p. 823-840
|
article
|
| 31 |
Benefit–Risk Assessment of Fish Oil in Preventing Cardiovascular Disease
|
Lands, Bill
|
|
2016
|
|
9 |
p. 787-799
|
article
|
| 32 |
Benefit-Risk Assessment of Linezolid for Serious Gram-Positive Bacterial Infections
|
Falagas, Matthew E.
|
|
2008
|
|
9 |
p. 753-768
|
article
|
| 33 |
Benefit-Risk Assessment of Linezolid for Serious Gram-Positive Bacterial Infections
|
Falagas, Matthew E.
|
|
|
|
9 |
p. 753-768
|
article
|
| 34 |
Benefit-Risk Assessment of Sunitinib in Gastrointestinal Stromal Tumours and Renal Cancer
|
Theou-Anton, Nathalie
|
|
|
|
9 |
p. 717-734
|
article
|
| 35 |
Can Social Media Benefit Drug Safety?
|
Franzen, Willibert
|
|
2011
|
|
9 |
p. 793
|
article
|
| 36 |
Cardiovascular Effects of Methylphenidate, Amphetamines and Atomoxetine in the Treatment of Attention-Deficit Hyperactivity Disorder: An Update
|
Awudu, Gariba A. H.
|
|
2014
|
|
9 |
p. 661-676
|
article
|
| 37 |
Cardiovascular Risks of Diclofenac Versus Other Older COX-2 Inhibitors (Meloxicam and Etodolac) and Newer COX-2 Inhibitors (Celecoxib and Etoricoxib): A Series of Nationwide Emulated Trials
|
Schmidt, Morten
|
|
|
|
9 |
p. 983-994
|
article
|
| 38 |
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians
|
Raschi, Emanuel
|
|
|
|
9 |
p. 819-833
|
article
|
| 39 |
Channeling Bias in the Analysis of Risk of Myocardial Infarction, Stroke, Gastrointestinal Bleeding, and Acute Renal Failure with the Use of Paracetamol Compared with Ibuprofen
|
Weinstein, Rachel B.
|
|
|
|
9 |
p. 927-942
|
article
|
| 40 |
Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions
|
Li, Ying
|
|
|
|
9 |
p. 893-903
|
article
|
| 41 |
Comment on: “Deliberate Self-Poisoning: Real-Time Characterisation of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System”
|
Cappello, Emiliano
|
|
|
|
9 |
p. 917-918
|
article
|
| 42 |
Comment on: "Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment Using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)"
|
Braillon, Alain
|
|
|
|
9 |
p. 1007-1009
|
article
|
| 43 |
Comparison of Data on Serious Adverse Events and Mortality in ClinicalTrials.gov, Corresponding Journal Articles, and FDA Medical Reviews: Cross-Sectional Analysis
|
Pradhan, Richeek
|
|
2018
|
|
9 |
p. 849-857
|
article
|
| 44 |
Computer Calculated Dose in Paediatric Prescribing
|
Kirk, Richard C.
|
|
2005
|
|
9 |
p. 817-824
|
article
|
| 45 |
Correction to: Impact of Policy Interventions on Oxycodone Prescribing in Queensland, Australia: An Uncontrolled Interrupted Time Series Study
|
Tumusiime, William
|
|
|
|
9 |
p. 1009-1010
|
article
|
| 46 |
Correction to: Provision and Need for Medicine Information in Asia and Africa: A Scoping Review of the Literature
|
Nualdaisri, Pitchaya
|
|
|
|
9 |
p. 1015
|
article
|
| 47 |
Detection of Drug–Drug Interactions Inducing Acute Kidney Injury by Electronic Health Records Mining
|
Girardeau, Yannick
|
|
2015
|
|
9 |
p. 799-809
|
article
|
| 48 |
Differences in the Recurrence Rate of Immediate Adverse Drug Reactions According to the Components of Alternative Contrast Media: Analysis of Repetitive Computed Tomography Cases in a Single Tertiary Hospital
|
Kim, Sung-Ryeol
|
|
|
|
9 |
p. 995-1002
|
article
|
| 49 |
Disproportionality Analysis of Abemaciclib in the FDA Adverse Event Reporting System: A Real-World Post-Marketing Pharmacovigilance Assessment
|
Shu, Yamin
|
|
|
|
9 |
p. 881-895
|
article
|
| 50 |
Dosage Effects of Histamine-2 Receptor Antagonist on the Primary Prophylaxis of Non-Steroidal Anti-Inflammatory Drug (NSAID)-Associated Peptic Ulcers: A Retrospective Cohort Study
|
He, Ying
|
|
2014
|
|
9 |
p. 711-721
|
article
|
| 51 |
Drug Fever
|
Vodovar, Dominique
|
|
2012
|
|
9 |
p. 759-767
|
article
|
| 52 |
Drug Fever
|
Vodovar, Dominique
|
|
2012
|
|
9 |
p. 759-767
|
article
|
| 53 |
Drug Fever
|
Vodovar, Dominique
|
|
|
|
9 |
p. 759-767
|
article
|
| 54 |
Drug-Induced Hyperkalemia
|
Ben Salem, Chaker
|
|
2014
|
|
9 |
p. 677-692
|
article
|
| 55 |
Drug-Induced Hypomagnesaemia
|
Atsmon, Jacob
|
|
2005
|
|
9 |
p. 763-788
|
article
|
| 56 |
Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature
|
Sarges, Philip
|
|
|
|
9 |
p. 801-821
|
article
|
| 57 |
Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature
|
Sarges, Philip
|
|
2016
|
|
9 |
p. 801-821
|
article
|
| 58 |
Drug Interactions in Dying Patients
|
Frechen, Sebastian
|
|
2012
|
|
9 |
p. 745-758
|
article
|
| 59 |
Drug Interactions in Dying Patients
|
Frechen, Sebastian
|
|
2012
|
|
9 |
p. 745-758
|
article
|
| 60 |
Drug Interactions in Dying Patients
|
Frechen, Sebastian
|
|
|
|
9 |
p. 745-758
|
article
|
| 61 |
Drug Interactions of Direct-Acting Oral Anticoagulants
|
Fitzgerald, John Leonard
|
|
2016
|
|
9 |
p. 841-845
|
article
|
| 62 |
Drug Safety in Geriatric Patients: Current Status and Proposed Way Forward
|
Furlan, Giovanni
|
|
|
|
9 |
p. 853-866
|
article
|
| 63 |
Drug Safety Monitoring in Children: Performance of Signal Detection Algorithms and Impact of Age Stratification
|
Osokogu, Osemeke U.
|
|
2016
|
|
9 |
p. 873-881
|
article
|
| 64 |
Drug Treatment of Depression in HIV-Positive Patients
|
Pieper, Andrew A.
|
|
2005
|
|
9 |
p. 753-762
|
article
|
| 65 |
Early Investigation of QTc Liability
|
Shah, Rashmi R.
|
|
2012
|
|
9 |
p. 695-709
|
article
|
| 66 |
Early Investigation of QTc Liability
|
Shah, Rashmi R.
|
|
2012
|
|
9 |
p. 695-709
|
article
|
| 67 |
Early Investigation of QTc Liability
|
Shah, Rashmi R.
|
|
|
|
9 |
p. 695-709
|
article
|
| 68 |
Effectiveness of Pharmacovigilance Training of General Practitioners
|
Gerritsen, Roald
|
|
2011
|
|
9 |
p. 755-762
|
article
|
| 69 |
Enabling Data-Driven Clinical Quality Assurance: Predicting Adverse Event Reporting in Clinical Trials Using Machine Learning
|
Ménard, Timothé
|
|
2019
|
|
9 |
p. 1045-1053
|
article
|
| 70 |
Erratum to: Methodological Approaches to Evaluate the Impact of FDA Drug Safety Communications
|
Kesselheim, Aaron S.
|
|
2015
|
|
9 |
p. 845
|
article
|
| 71 |
Evaluation of Potential Drug–Drug Interactions in Adults in the Intensive Care Unit: A Systematic Review and Meta-Analysis
|
Fitzmaurice, Mary Grace
|
|
2019
|
|
9 |
p. 1035-1044
|
article
|
| 72 |
Evaluation of Potential Drug–Drug Interactions in Adults in the Intensive Care Unit: A Systematic Review and Meta-Analysis
|
Fitzmaurice, Mary Grace
|
|
|
|
9 |
p. 1035-1044
|
article
|
| 73 |
Evaluation of the Case–Crossover (CCO) Study Design for Adverse Drug Event Detection
|
Burningham, Zachary
|
|
2017
|
|
9 |
p. 789-798
|
article
|
| 74 |
Evaluation of Use of Technologies to Facilitate Medical Chart Review
|
Straub, Loreen
|
|
2019
|
|
9 |
p. 1071-1080
|
article
|
| 75 |
Exploring the Potential Routine Use of Electronic Healthcare Record Data to Strengthen Early Signal Assessment in UK Medicines Regulation: Proof-of-Concept Study
|
Donegan, Katherine
|
|
2018
|
|
9 |
p. 899-910
|
article
|
| 76 |
Finding Needles in the Haystack: Clinical Utility Score for Prioritisation (CUSP), an Automated Approach for Identifying Spontaneous Reports with the Highest Clinical Utility
|
Kara, Vijay
|
|
|
|
9 |
p. 847-855
|
article
|
| 77 |
Fluoroquinolone Use and the Risk of Collagen-Associated Adverse Events: A Systematic Review and Meta-Analysis
|
Yu, Xinyu
|
|
2019
|
|
9 |
p. 1025-1033
|
article
|
| 78 |
Healthcare Databases for Drug Safety Research: Data Validity Assessment Remains Crucial
|
Rawson, Nigel S. B.
|
|
2018
|
|
9 |
p. 829-833
|
article
|
| 79 |
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance
|
Mascolo, Annamaria
|
|
|
|
9 |
p. 957-971
|
article
|
| 80 |
Impact of Policy Interventions on Oxycodone Prescribing in Queensland, Australia: An Uncontrolled Interrupted Time Series Study
|
Tumusiime, William
|
|
|
|
9 |
p. 941-949
|
article
|
| 81 |
Implications of the IQ-CSRC Prospective Study: Time to Revise ICH E14
|
Darpo, Borje
|
|
2015
|
|
9 |
p. 773-780
|
article
|
| 82 |
Incidence and Economic Burden of Adverse Drug Reactions among Elderly Patients in Ontario Emergency Departments
|
Wu, Chen
|
|
2012
|
|
9 |
p. 769-781
|
article
|
| 83 |
Incidence and Economic Burden of Adverse Drug Reactions among Elderly Patients in Ontario Emergency Departments
|
Wu, Chen
|
|
2012
|
|
9 |
p. 769-781
|
article
|
| 84 |
Incidence and Economic Burden of Adverse Drug Reactions among Elderly Patients in Ontario Emergency Departments
|
Wu, Chen
|
|
|
|
9 |
p. 769-781
|
article
|
| 85 |
Indigenous Medicine Use for Sex Selection During Pregnancy and Risk of Congenital Malformations: A Population-Based Case-Control Study in Haryana, India
|
Neogi, Sutapa Bandyopadhyay
|
|
|
|
9 |
p. 789-797
|
article
|
| 86 |
Indigenous Medicine Use for Sex Selection During Pregnancy and Risk of Congenital Malformations: A Population-Based Case-Control Study in Haryana, India
|
Neogi, Sutapa Bandyopadhyay
|
|
2015
|
|
9 |
p. 789-797
|
article
|
| 87 |
Information Visualization Platform for Postmarket Surveillance Decision Support
|
Spiker, Jonathan
|
|
|
|
9 |
p. 905-915
|
article
|
| 88 |
Inhaled Corticosteroids and Adrenal Insufficiency
|
Molimard, Mathieu
|
|
2008
|
|
9 |
p. 769-774
|
article
|
| 89 |
INTERNATIONAL SOCIETY OF PHARMACOVIGILANCE
|
|
|
|
|
9 |
p. 793-951
|
article
|
| 90 |
Is There an Increased Risk of Hepatotoxicity with Metamizole? A Comparative Cohort Study in Incident Users
|
Hedenmalm, Karin
|
|
|
|
9 |
p. 973-985
|
article
|
| 91 |
Macrolides, Digoxin Toxicity and the Risk of Sudden Death: A Population-Based Study
|
Quinn, Kieran L.
|
|
2017
|
|
9 |
p. 835-840
|
article
|
| 92 |
Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study
|
Fusaroli, Michele
|
|
|
|
9 |
p. 857-866
|
article
|
| 93 |
Mass Psychogenic Illness After Vaccination
|
Clements, C. John
|
|
|
|
9 |
p. 599-604
|
article
|
| 94 |
Medications and Glucose-6-Phosphate Dehydrogenase Deficiency
|
Youngster, Ilan
|
|
|
|
9 |
p. 713-726
|
article
|
| 95 |
Methods for Retrospective Detection of Drug Safety Signals and Adverse Events in Electronic General Practice Records
|
Tomlin, Andrew
|
|
2012
|
|
9 |
p. 733-743
|
article
|
| 96 |
Methods for Retrospective Detection of Drug Safety Signals and Adverse Events in Electronic General Practice Records
|
Tomlin, Andrew
|
|
2012
|
|
9 |
p. 733-743
|
article
|
| 97 |
Methods for Retrospective Detection of Drug Safety Signals and Adverse Events in Electronic General Practice Records
|
Tomlin, Andrew
|
|
|
|
9 |
p. 733-743
|
article
|
| 98 |
Mortality in Children and Adolescents Prescribed Antipsychotic Medication
|
Rani, Fariz A.
|
|
2011
|
|
9 |
p. 773-781
|
article
|
| 99 |
Non-bleeding Adverse Events with the Use of Direct Oral Anticoagulants: A Sequence Symmetry Analysis
|
Maura, Géric
|
|
2018
|
|
9 |
p. 881-897
|
article
|
| 100 |
NSAIDs and COVID-19: A Systematic Review and Meta-analysis
|
Moore, Nicholas
|
|
|
|
9 |
p. 929-938
|
article
|
| 101 |
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping
|
Antonazzo, Ippazio Cosimo
|
|
2017
|
|
9 |
p. 823-834
|
article
|
| 102 |
On Pharmaceutical Risk Minimization
|
Callréus, Torbjőrn
|
|
2008
|
|
9 |
p. 737-742
|
article
|
| 103 |
Osteoporosis-Related Fractures in HIV-Infected Patients Receiving Long-Term Tenofovir Disoproxil Fumarate: An Observational Cohort Study
|
Komatsu, Ayami
|
|
2018
|
|
9 |
p. 843-848
|
article
|
| 104 |
Pancreas and Adverse Drug Reactions: A Literature Review
|
Sosnowski, Konrad
|
|
|
|
9 |
p. 929-939
|
article
|
| 105 |
Pathophysiology of Drug-Induced Hypomagnesaemia
|
Katopodis, Periklis
|
|
|
|
9 |
p. 867-880
|
article
|
| 106 |
Patient-Reported Burden of Adverse Drug Reactions Attributed to Biologics Used for Immune-Mediated Inflammatory Diseases
|
van Lint, Jette A.
|
|
|
|
9 |
p. 917-925
|
article
|
| 107 |
Patient-Reported Reasons for Switching or Discontinuing Statin Therapy: A Mixed Methods Study Using Social Media
|
Golder, Su
|
|
|
|
9 |
p. 971-981
|
article
|
| 108 |
Physicians’ Attitudes and Adverse Drug Reaction Reporting
|
Herdeiro, Maria T.
|
|
2005
|
|
9 |
p. 825-833
|
article
|
| 109 |
Potential Teratogenic Effects of Clomiphene Citrate
|
Scaparrotta, Alessandra
|
|
2017
|
|
9 |
p. 761-769
|
article
|
| 110 |
Prevalence, Nature, Severity and Risk Factors for Prescribing Errors in Hospital Inpatients: Prospective Study in 20 UK Hospitals
|
Ashcroft, Darren M.
|
|
2015
|
|
9 |
p. 833-843
|
article
|
| 111 |
Prevalence, Safety and Long-Term Retention Rates of Biologics in Hong Kong from 2001 to 2015
|
Ge, Mengqin
|
|
2019
|
|
9 |
p. 1091-1102
|
article
|
| 112 |
Psychiatric Adverse Events Associated with Varenicline
|
Harrison-Woolrych, Mira
|
|
2011
|
|
9 |
p. 763-772
|
article
|
| 113 |
Randomized Controlled Trials of COX-2 Inhibitors
|
Stefansdottir, Gudrun
|
|
2011
|
|
9 |
p. 783-792
|
article
|
| 114 |
Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy Volunteers
|
Ackert, Jessica
|
|
2019
|
|
9 |
p. 1103-1114
|
article
|
| 115 |
Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020
|
Rocca, Elena
|
|
|
|
9 |
p. 987-998
|
article
|
| 116 |
RevAssist®
|
Castaneda, Carmen P.
|
|
2008
|
|
9 |
p. 743-752
|
article
|
| 117 |
Risk Factors Associated with Adverse Drug Reactions Following Hospital Admission
|
Zopf, Yurdaguel
|
|
2008
|
|
9 |
p. 789-798
|
article
|
| 118 |
Risk of Hypospadias in Offspring of Women Using Loratadine during Pregnancy
|
Schwarz, Eleanor B.
|
|
2008
|
|
9 |
p. 775-788
|
article
|
| 119 |
Role of Medicines of Unknown Identity in Adverse Drug Reaction-Related Hospitalizations in Developing Countries: Evidence from a Cross-Sectional Study in a Teaching Hospital in the Lao People’s Democratic Republic
|
Caillet, Céline
|
|
2017
|
|
9 |
p. 809-821
|
article
|
| 120 |
Safety and Tolerability of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: Results of the ProCID Study
|
Cornblath, David R.
|
|
|
|
9 |
p. 835-845
|
article
|
| 121 |
Safety and Tolerability Profiles of Anticholinergic Agents Used for the Treatment of Overactive Bladder
|
Oefelein, Michael G.
|
|
2011
|
|
9 |
p. 733-754
|
article
|
| 122 |
Safety Experience During Real-World Use of Injectable Artesunate in Public Health Facilities in Ghana and Uganda: Outcomes of a Modified Cohort Event Monitoring Study (CEMISA)
|
Ampadu, H. Hilda
|
|
2018
|
|
9 |
p. 871-880
|
article
|
| 123 |
Safety of Calcium Dobesilate in Chronic Venous Disease, Diabetic Retinopathy and Haemorrhoids
|
Allain, Hervé
|
|
|
|
9 |
p. 649-660
|
article
|
| 124 |
Safety of Tamsulosin: A Systematic Review of Randomized Trials with a Focus on Women and Children
|
Kaplan, Steven A.
|
|
2018
|
|
9 |
p. 835-842
|
article
|
| 125 |
Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic Review of Population-Based Studies
|
Hirsch, Lauren
|
|
2017
|
|
9 |
p. 771-781
|
article
|
| 126 |
Study of Natural Products Adverse Reactions (SONAR) in Adults with Mental Health Conditions: A Cross-Sectional Study
|
Zorzela, Liliane
|
|
|
|
9 |
p. 999-1006
|
article
|
| 127 |
The Author’s Reply
|
Ralph Edwards, I.
|
|
2011
|
|
9 |
p. 793-794
|
article
|
| 128 |
The Incidence of Drug- and Herbal and Dietary Supplement-Induced Liver Injury: Preliminary Findings from Gastroenterologist-Based Surveillance in the Population of the State of Delaware
|
Vega, Maricruz
|
|
2017
|
|
9 |
p. 783-787
|
article
|
| 129 |
The Patient’s Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization
|
Smith, Meredith Y.
|
|
2016
|
|
9 |
p. 779-785
|
article
|
| 130 |
The QTc-Bazett Interval in Former Very Preterm Infants in Adolescence and Young Adulthood is Not Different from Term-Born Controls
|
Vanthienen, Jill
|
|
|
|
9 |
p. 897-904
|
article
|
| 131 |
The Risk of Opioid Intoxications or Related Events and the Effect of Alcohol-Related Disorders: A Retrospective Cohort Study in German Patients Treated with High-Potency Opioid Analgesics
|
Jobski, K.
|
|
2015
|
|
9 |
p. 811-822
|
article
|
| 132 |
The Role of P-Glycoprotein and Organic Anion-Transporting Polypeptides in Drug Interactions
|
DuBuske, Lawrence M.
|
|
2005
|
|
9 |
p. 789-801
|
article
|
| 133 |
Thromboembolic Safety Reporting of Tofacitinib and Baricitinib: An Analysis of the WHO VigiBase
|
Vallejo-Yagüe, Enriqueta
|
|
|
|
9 |
p. 881-891
|
article
|
| 134 |
Thromboembolism and Janus Kinase Inhibitors
|
Ibrahim, Fowzia
|
|
|
|
9 |
p. 831-833
|
article
|
| 135 |
Tolerability and Safety of the New Anti-Obesity Medications
|
Hainer, Vojtech
|
|
2014
|
|
9 |
p. 693-702
|
article
|
| 136 |
Use of Bisphosphonates and the Risk of Skin Ulcer: A National Cohort Study Using Data from the French Health Care Claims Database
|
Jambon-Barbara, Clément
|
|
|
|
9 |
p. 905-916
|
article
|
| 137 |
Use of Social Media for Pharmacovigilance Activities: Key Findings and Recommendations from the Vigi4Med Project
|
Audeh, Bissan
|
|
|
|
9 |
p. 835-851
|
article
|
| 138 |
Using Simulated Data to Assess Case-Crossover Designs for Studying Less Transient Effects of Drugs
|
Maclure, Malcolm
|
|
2017
|
|
9 |
p. 757-760
|
article
|
| 139 |
Vaccine–Drug Interactions: Cytokines, Cytochromes, and Molecular Mechanisms
|
Pellegrino, Paolo
|
|
2015
|
|
9 |
p. 781-787
|
article
|
| 140 |
Variation in Association Between Thiazolidinediones and Heart Failure Across Ethnic Groups: Retrospective analysis of Large Healthcare Claims Databases in Six Countries
|
Roughead, Elizabeth E.
|
|
2015
|
|
9 |
p. 823-831
|
article
|
| 141 |
Vitamin B6 in Health Supplements and Neuropathy: Case Series Assessment of Spontaneously Reported Cases
|
Hunsel, Florence van
|
|
2018
|
|
9 |
p. 859-869
|
article
|
| 142 |
Walking the Fine Line between Science and Culture
|
Shulman, Lee P.
|
|
2015
|
|
9 |
p. 769-771
|
article
|
| 143 |
When Should Vaccination Be Contraindicated in Children?
|
Lane, Laura
|
|
2005
|
|
9 |
p. 743-752
|
article
|
| 144 |
Zoo or Savannah? Choice of Training Ground for Evidence-Based Pharmacovigilance
|
Norén, G. Niklas
|
|
2014
|
|
9 |
p. 655-659
|
article
|
Journal description